These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27928266)

  • 1. Relationship between Structural and Functional Assessment of the Visual System in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients.
    Huseyinoglu N; Ekinci M; Ozben S; Buyukuysal C
    Neuroophthalmology; 2014; 38(1):1-7. PubMed ID: 27928266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
    Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
    Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.
    Monteiro ML; Fernandes DB; Apóstolos-Pereira SL; Callegaro D
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3959-66. PubMed ID: 22589446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
    Klistorner A; Garrick R; Barnett MH; Graham SL; Arvind H; Sriram P; Yiannikas C
    Neurology; 2013 Jan; 80(3):242-5. PubMed ID: 23269599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis.
    Chatziralli IP; Moschos MM; Brouzas D; Kopsidas K; Ladas ID
    Clin Exp Optom; 2012 Mar; 95(2):223-8. PubMed ID: 22329676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography.
    Fjeldstad C; Bemben M; Pardo G
    J Clin Neurosci; 2011 Nov; 18(11):1469-72. PubMed ID: 21917458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
    Yilmaz Ü; Gücüyener K; Erin DM; Yazar Z; Gürkaş E; Serdaroğlu A; Tepe N; Demir E
    J Child Neurol; 2012 Dec; 27(12):1517-23. PubMed ID: 22752482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis without Optic Neuritis: A 20-Month Longitudinal Study.
    Huseyinoglu N; Ozben S; Ekinci M; Buyukuysal C; Yıldırım M; Safak H; Huseyin H
    Neuroophthalmology; 2013; 37(3):104-110. PubMed ID: 28163764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of retinal nerve fibre layer thickness with visual evoked potential and visual field in patients with multiple sclerosis.
    Alpay A; Guney T; Unal A; Ugurbas SH
    Clin Exp Ophthalmol; 2012; 40(1):e25-31. PubMed ID: 21668781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of macular and nerve fiber layer thickness in multiple sclerosis patients according to severity level and optic neuritis episodes.
    Soler García A; Padilla Parrado F; Figueroa-Ortiz LC; González Gómez A; García-Ben A; García-Ben E; García-Campos JM
    Neurologia; 2016; 31(6):379-88. PubMed ID: 25529178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
    Tugcu B; Soysal A; Kılıc M; Yuksel B; Kale N; Yıgıt U; Arpaci B
    J Neurol Sci; 2013 Dec; 335(1-2):182-5. PubMed ID: 24148562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
    Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
    Mult Scler; 2010 Apr; 16(4):412-26. PubMed ID: 20207786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients.
    Garcia-Martin E; Pueyo V; Almarcegui C; Martin J; Ara JR; Sancho E; Pablo LE; Dolz I; Fernandez J
    Br J Ophthalmol; 2011 Nov; 95(11):1577-82. PubMed ID: 21785155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography and disease subtype in multiple sclerosis.
    Pulicken M; Gordon-Lipkin E; Balcer LJ; Frohman E; Cutter G; Calabresi PA
    Neurology; 2007 Nov; 69(22):2085-92. PubMed ID: 18040015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
    Burkholder BM; Osborne B; Loguidice MJ; Bisker E; Frohman TC; Conger A; Ratchford JN; Warner C; Markowitz CE; Jacobs DA; Galetta SL; Cutter GR; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2009 Nov; 66(11):1366-72. PubMed ID: 19901168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
    Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
    Di Maggio G; Santangelo R; Guerrieri S; Bianco M; Ferrari L; Medaglini S; Rodegher M; Colombo B; Moiola L; Chieffo R; Del Carro U; Martinelli V; Comi G; Leocani L
    Mult Scler; 2014 Sep; 20(10):1342-7. PubMed ID: 24591532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.